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Ca2þ Leak in Atrial Fibrillation
Junctophilin-2 Stabilizes
Ryanodine Receptor*
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Atrial ﬁbrillation (AF), the most common sustained cardiac
arrhythmia, poses a formidable challenge to modern-day
medicine. AF affects as many as 5 million Americans (1),
and responses to therapy are highly variable among patients.
Some therapies are fraught with substantial risk of proar-
rhythmia. As our population ages, the incidence of this
rhythm disturbance, which can be associated with markedly
increased morbidity and mortality, will continue to increase.
Although strides have been made in elucidating underlying
mechanisms, key molecular events remain elusive (2).See page 2010Cytosolic Ca2þ governs a wide range of events in cardiac
myocytes, including excitation-contraction coupling, sig-
naling events, and activation of enzymes. As such, intra-
cellular Ca2þ levels are tightly regulated in a context wherein
they ﬂuctuate 50-fold with each contraction. Ca2þ inﬂux
occurs through plasma-membrane localized L-type Ca2þ
channels (LTCCs), which trigger much greater Ca2þ release
from the sarcoplasmic reticulum (SR) via opening of the SR
Ca2þ release channel (ryanodine receptor type 2 [RYR2])
(3). With repolarization, cytosolic Ca2þ is rapidly returned
to the SR by the SR ATPase or extruded from the cell via
the plasma membrane–localized sodium-calcium exchanger
(NCX) (3).
Elevated cytosolic Ca2þ levels during diastole, as well as
transient increases in Ca2þ (“sparks”), are capable of trig-
gering delayed afterdepolarizations (DADs) and focal
ectopic electrical activity, each of which is implicated in atrial
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myocytes from patients with chronic AF (4–7). Intriguingly,
similar events occur in catecholaminergic polymorphic
ventricular tachycardia, in which genetic mutations in RYR2
are implicated (8).
RYR2, a large tetrameric membrane protein (>500 kDa),
is localized to the junctional membrane complex (JMC),
a point of apposition between plasma membrane and the
endoplasmic reticulum/SR (9). JMCs are a feature common
to all excitable cell types, serving to facilitate cross-talk
between the cell surface (speciﬁcally, its invaginations as
transverse (T) tubules) and intracellular ion channels.
Junctophilin-2, the dominant cardiac-expressed junctophilin
isoform (10), is an essential component of JMCs.
In this issue of the Journal, Beavers et al. (11) report
a previously undescribed mutation in the gene coding for
junctophilin-2 in an individual afﬂicted with paroxysmal AF
and hypertrophic cardiomyopathy. The authors go on to
dissect mechanisms by which mutations in this protein
participate in dysregulation of SR Ca2þ release in patients
with paroxysmal AF and structural heart disease.
Previous work from this group focusing on nonischemic
cardiomyopathy has demonstrated that hyperphosphorylation
of RYR2, mediated by Ca2þ/calmodulin-dependent protein
kinase II (CaMKII), provokes spontaneous channel opening
with persistent Ca2þ leak from the SR (12). These same
authors (7,13) and others (5) have reported this phenomenon
in atrial cardiomyocytes from patients with chronic AF.
Again, elevated cytosolic Ca2þ levels and spontaneous SR
Ca2þ release events (i.e., sparks) that provoke DADs were
implicated in the arrhythmogenic state. The study reported
here suggests that a similar mechanism may predispose to
atrial arrhythmias (11).
This report makes a signiﬁcant contribution in its careful
elucidation of the role of junctophilin-2 in the molecular
pathogenesis of RYR2 Ca2þ leak (11). The work was
informed by the observation that adult-onset deﬁciency of
junctophilin-2 in mice results in disruption of the JMCs
with mislocalization of RYR2s and LTCCs, increased dia-
stolic Ca2þ leak from the SR, and Ca2þ sparks (14). The
authors were also guided by previous reports of missense
mutations in JPH2, the gene coding for junctophilin-2, in
patients with hypertrophic cardiomyopathy (15,16), which
were observed to alter Ca2þ signaling in myocytes in vitro
(15,17).
Here, the authors discovered 2 novel missense mutations in
the JPH2 coding region on screening a population of patients
with hypertrophic cardiomyopathy, one of which was associ-
ated with paroxysmal AF in the proband and supraventricular
arrhythmias in his father (11). They modeled these 2 muta-
tions in mice using a clever strategy of crossing a transgenic
mouse expressing mutant JPH2 with cardiomyocyte-speciﬁc
JPH2 knockdown mice. The resultant “pseudo-knockin”
mice manifested myocardial junctophilin-2 expression at levels
equivalent to those of wild type, while harboring a mix of both
mutant and wild-type protein (11) akin to the situation in
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2021patients heterozygous for these mutations. Remarkably, only
the mice carrying the glutamate-to-lysine mutation at posi-
tion 169 in human junctophilin-2 (E169K, detected in
the proband with atrial ﬁbrillation), manifested increased
susceptibility to pacing-induced AF, spontaneous SR Ca2þ
release events, and increased RYR2 open probability (11).
Additionally, only the E169K mutant protein demonstrated
diminished interaction with RYR2, implicating this region of
junctophilin-2 in stabilizing RYR2 in its closed state.
Beavers et al. (11) map critical aspects of junctophilin-2
interaction with RYR2 to a speciﬁc region of the
junctophilin-2 protein. Seizing this observation, they ﬁnd
that overexpression of a short peptide mimicking this region
attenuated Ca2þ spark frequency and RYR2 open proba-
bility. Whether a similar mechanism provokes alterations in
Ca2þ signaling observed with expression of the S165F and
Y141H mutants (17,18) remains to be determined.
Previous studies have implicated increased CaMKII-
mediated phosphorylation of RYR2 in AF pathogenesis
(5,7,13). Indeed, CaMKII-mediated RYR2 phosphorylation
at S2814 was noted to be essential for conferring arrhythmia
susceptibility in a mouse model of RYR2 gain-of-function
(13). Further, knock-in of S2814A (nonphosphorylatable)
and S2814D (phosphomimetic) RYR2 mutants attenuated
and exacerbated AF susceptibility, respectively (7,19). Also,
loss of FKBP12.6, a RYR2-stabilizing protein, provokes SR
Ca2þ leak and predisposes to atrial arrhythmias (6,19).
As with all discoveries, this elegant study raises new
questions. Given the small sample size studied here and the
lack of a matched control group, the association of the re-
ported JPH2 mutations with hypertrophic cardiomyopathy
remains to be conﬁrmed. Notwithstanding this limitation,
earlier studies have suggested that mutations resulting in
alteration in junctophilin-2 function are associated with
hypertrophic cardiomyopathy (15,16). Indeed, reduced
junctophilin-2 abundance is observed in left ventricular tissue
from patients with hypertrophic cardiomyopathy harboring
diverse mutations in sarcomeric and other genes, and
junctophilin-2 knockdown provokes cardiomyocyte hyper-
trophy in vitro (17).
A recent study modeled hypertrophic cardiomyopathy in
induced pluripotent stem cells generated from a family of
individuals harboring a mutation in the b-myosin heavy
chain gene (MYH7) (20). Cardiomyocytes transdifferentiated
from these cells manifested elevations in cytosolic Ca2þ and
frequent small depolarizations with increased propensity to
generate DADs, preceding spontaneous development of
hypertrophy (20). Conversely, elevations of cytosolic Ca2þ, as
observed with the E169K junctophilin-2 mutant, may be
speculated to drive expression of prohypertrophic transcrip-
tion factors such as MEF-2, which is activated in a mouse
model of hypertrophic cardiomyopathy provoked by a distinct
human MYH7 mutation (21).
Interestingly, the current report did not describe hyper-
trophy in mice expressing the junctophilin-2 mutants (11),
and earlier studies with cardiomyocyte-speciﬁc junctophilin-2 knockdown in vivo did not report hypertrophy (14). Thus,
further work is needed to establish a putative cause-and-
effect relationship between reduced junctophilin-2 function
and hypertrophy. One might speculate that reduced
junctophilin-2 function may be sufﬁcient to drive the
pathogenesis of hypertrophy via mechanisms currently not
deﬁned, as with the alanine-to-serine mutation at position
405, which was detected in an individual with hypertrophic
cardiomyopathy but did not alter Ca2þ cycling (11). It also
plausible that the primary effect of reduced junctophilin-2
function may be to confer susceptibility to arrhythmo-
genesis, with elevated diastolic Ca2þ levels provoking
accelerated prohypertrophic signaling as a disease-modifying
event.
Another interesting observation from this study is
a reduction in the ratio of junctophilin-2 to RYR2 abundance
in atrial tissue from patients with paroxysmal AF and struc-
tural heart disease, eliciting relative junctophilin-2 deﬁciency
driven primarily by up-regulation of RYR2 abundance (11).
The authors speculate that this relative deﬁciency fosters
destabilization of RYR2 with resultant Ca2þ leak from the
SR (7). Indeed, an inverse correlation between myocardial
junctophilin-2 levels and susceptibility to AF induction in
the Beavers et al. (11) study lends support to this notion.
Although gene expression changes in Ca2þ cycling proteins
were not observed in a previous study of right atrial tissue
from a comparable patient population with paroxysmal AF
(22), junctophilin-2 expression was not evaluated, and
interindividual variability with small sample sizes precludes
direct comparisons with the current study. Whether a relative
or absolute reduction in junctophilin-2 expression and/or
function occurs in atrial myocytes from patients with chronic
AF remains to be determined. It is also intriguing to note that
genomewide association studies in AF patients have not
uncovered mutations or polymorphisms in JPH2, which may
indicate that deﬁcient junctophilin-2 function or expression
may be rare and/or not the primary driver of pathogenesis.
Accumulating evidence from preclinical studies points to
JMC remodeling in post-myocardial infarction heart failure
(23) and pressure overload–induced hypertrophy (24). These
changes are associated with reduced junctophilin-2 abun-
dance and decreased coupling of LTCC with RYR2 in the
ventricular myocardium, suggesting that deﬁciency of
junctophilin-2 may confer susceptibility to ventricular
arrhythmogenesis across several common forms of cardiac
pathology. Reductions in junctophilin-2 expression may be
the primary event in provoking T-tubule (and JMC)
dysfunction, as suggested by the observation of miR-24–
induced suppression of junctophilin-2 transcription in pres-
sure overload–induced hypertrophy (25). Indeed, restoring
junctophilin-2 expression in vivo with a miR-24–targeting
antagomir preserved T-tubule architecture without affecting
the hypertrophic response (25). Reductions in junctophilin-2
expression may also occur via calpain-mediated proteolysis
(26), conceivably provoking JMC disruption and Ca2þ
cycling abnormalities.
Hill and Diwan JACC Vol. 62, No. 21, 2013
Ca2+ Leak in Atrial Fibrillation November 19/26, 2013:2020–2
2022The current study raises additional questions. What is the
role of junctophilin-2 in the pathogenesis of ventricular
arrhythmias? Notably, the 2 individuals carrying the E169K
mutation demonstrated prolonged QTc, and the proband
required pacemaker implantation for sinoatrial exit block,
suggesting effects of the mutation beyond the atrial myocyte
(11). Also, the mechanistic relevance of these ﬁndings to
human AF is perhaps better explored in large animal
models, which have a well-developed T-tubule network in
atrial myocytes versus the rudimentary T-tubule system in
rodents (27).
Notwithstanding our present lack of understanding as to
whether junctophilin-2 deﬁciency is an initiator or propa-
gator of arrhythmias, the current study along with previous
work supports a role for junctophilin-2 deﬁciency in
fostering Ca2þ leak from the SR and consequent proar-
rhythmia. These data suggest that preventing junctophilin-2
dysfunction or deﬁciency and, by corollary, restoring the
structure of the JMC, may be a meaningful therapeutic
target in abrogating certain rhythm disturbances. Indeed,
demonstration here of efﬁcacy of a small junctophilin-2
peptide in stabilizing RYR2 and preventing SR Ca2þ leak
is a ﬁrst step toward translating this notion into practice.Reprint requests and correspondence: Dr. Joseph A. Hill,
Division of Cardiology, UT Southwestern Medical Center,
NB11.200, 6000 Harry Hines Boulevard, Dallas, Texas 75390-
8573. E-mail: joseph.hill@utsouthwestern.edu.REFERENCES
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